Is the blockbuster imperative broken

doi:10.1016/j.drudis.2023.103789

2023-11-01

PRE

Alexander Schuhmacher *

DOI：10.1016/j.drudis.2023.103789

原文链接

原文求助

摘要

Keyword:

DRUGS

期刊

Drug Discovery Today

IF:

7.5

论文数:

6.4K

被引数:

2.3W

机构

eberhard karls university of tubingen

学者数:

3.3W

论文数: 2.5W

被引数: 38

Novartis

学者数:

1.8W

论文数: 9.5K

被引数: 2.9K

引用论文

The 'big pharma' dilemma: develop new drugs or promote existing ones?

NATURE REVIEWS DRUG DISCOVERY

IF101.8

2009-06-19

PREAI

Weiss, Dan; Naik, Prasad; Weiss, Ram

Trends in Prescription Drug Launch Prices, 2008-2021

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IF55

2022-06-07

OAAI

Rome, Benjamin N.; Egilman, Alexander C.; Kesselheim, Aaron S.

Evolution of the market for mRNA technology

NATURE REVIEWS DRUG DISCOVERY

IF101.8

2021-09-02

PREAI

Xie, Wen; Chen, Baiping; Wong, John

Analysis of pharma R&D productivity - a new perspective needed 制药研发生产率分析 -- 需要一个新的视角

DRUG DISCOVERY TODAY

IF7.5

2023-10-01

PREAI

Schuhmacher, Alexander; Hinder, Markus; Stein, Alexander von Stegmann und; Hartl, Dominik; Gassmann, Oliver

FROM THE ANALYST'S COUCH Developing blockbuster drugs: both nature and nurture

NATURE REVIEWS DRUG DISCOVERY

IF101.8

2020-06-08

PREAI

Pont, Lotte Berghauser; Keirsse, Jiri; Moss, Rachel; Poda, Pawel; Robke, Lucas; Wurzer, Stephan